| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xencor, Inc. (XNCR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. XNCR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 477.3K | $6.56M | - | |
| VP | 242.9K | $3.34M | - | |
| Dir | 110.4K | $1.52M | - | |
| CFO | 75.9K | $1.04M | - | |
| Dir | 15.5K | $213.8K | -5,064 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2024 | Dahiyat Bassil I74 | President &CEO | Sale+OE | 3,366 | $24.02 | $80,841.90 | -0.9% | -31.7% | -40.7% | |
| Nov 11, 2024 | Desjarlais John R76 | Sr. Vice President &CSO | Sale+OE | 68,684 | $23.48 | $1,612,638.50 | -25.6% | -27.8% | -36.2% | |
| Sep 27, 2024 | Ranieri Richard J | Director | Sell | 2,503 | $20.68 | $51,762.04 | -22.8% | +22.5% | -42.9% | |
| Sep 27, 2024 | Rosa-Bjorkeson Dagmar | Director | Sell | 2,503 | $20.68 | $51,762.04 | -22.8% | +22.5% | -42.9% | |
| Sep 27, 2024 | Gustafson Kurt A81 | Director | Sell | 2,503 | $20.68 | $51,762.04 | -20.9% | +22.5% | -42.9% | |
| Sep 27, 2024 | Gorman Kevin Charles55 | Director | Sell | 2,654 | $20.68 | $54,884.72 | -24.0% | +22.5% | -42.9% | |
| Sep 27, 2024 | Montgomery Alan Bruce62 | Director | Sell | 1,853 | $20.68 | $38,320.04 | -16.9% | +22.5% | -42.9% | |
| Sep 27, 2024 | Feigal Ellen | Director | Sell | 2,503 | $20.68 | $51,762.04 | -22.8% | +22.5% | -42.9% | |
| Jul 9, 2024 | Desjarlais John R76 | Sr. Vice President &CSO | Sale+OE | 36,329 | $18.32 | $665,510.95 | -15.9% | +5.9% | -49.3% | |
| May 2, 2024 | Valente Nancy61 | EVP, Chief Development Officer | Sell | 4,745 | $23.58 | $111,871.92 | -7.9% | -13.6% | -52.3% |